Global Over the Counter (OTC) Drugs Markets, 2015-2020 & 2021-2025: Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Over the Counter (OTC) Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements [VMS], Other), By Dosage Form, By Distribution Channel, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Over the Counter (OTC) Drugs Market exceeded USD 140 billion in 2019 and is expected to grow at a CAGR of around 8.23% during the forecast period.
The Global Over the Counter (OTC) Drugs Market is driven by rising health consciousness among the population across the globe. Moreover, buying OTC drugs is cost effective as they need no prescription, which is expected to positively impact the growth of the market during the forecast period.
The availability and affordability of these medicines has further increased the adoption rates of the OTC drugs in the market. Also, rapidly expanding healthcare and pharmaceuticals industries, is further expected to bolster the growth of the market over the next few years.
The Global Over the Counter (OTC) Drugs Market is segmented based on product, dosage form, distribution channel, company, and region. Based on product, the market can be categorized into cough, cold and flu products, analgesics, dermatology products, vitamins, mineral and supplements (VMS) and other.
Out of these, the cough, cold, and flu products segment dominated the market in terms of largest market share until 2019 and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to growing number of infections which is leading to the rise in the number of infectious diseases.
The market is further driven by the increasing efforts to licencing of OTC drugs for the treatment of cough, cold and flu. In addition to this, vitamins, mineral, and supplements (VMS) segment is expected to grow at a high pace in the next 5 years on account of the rising popularity of VMS products in developed countries because of the increasing diseased population.
Based on the dosage form, the market is segmented into tablets, capsules, ointments, liquids, and powders. Out of these, tablets segment dominates the market and is expected to maintain its position. Tablets are usually preferred by the doctors and patients as it is the most convenient oral dosage form.
Based on the distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, online pharmacy, and others. Out of these, retail pharmacies segment is the leading segment as, these are easily accessible. Furthermore, retail pharmacies have availability of a variety of drugs.
The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer bases.
Major players operating in the Global Over the Counter (OTC) Drugs Market include
- Johnson and Johnson
- GlaxoSmithKline PLC (GSK Consumer Healthcare)
- Perrigo Company PLC
- Reckitt Benckiser Group PLC
- Takeda Pharmaceutical Company Ltd
- Roche Holding AG
- The Procter & Gamble Company
- Sanofi S.A
- Gilead Sciences Inc.
- Bayer Healthcare AG
- AstraZeneca plc.
- Alacer Corp.
- Alcon Inc.
Years considered for this report:
- Historical Years: 2015-2018
- Base Year: 2019
- Estimated Year: 2020
- Forecast Period: 2021-2025
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Over the Counter (OTC) Drugs Market
4. Executive Summary
5. Voice of Customer
6. Global Over the Counter (OTC) Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other)
6.2.2. By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids)
6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other)
6.2.4. By Company (2019)
6.2.5. By Region
6.3. Product Market Map
7. Asia-Pacific Over the Counter (OTC) Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Dosage Form
7.2.3. By Distribution Channel
7.2.4. By Country
8. Europe Over the Counter (OTC) Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Dosage Form
8.2.3. By Distribution Channel
8.2.4. By Country
9. North America Over the Counter (OTC) Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Dosage Form
9.2.3. By Distribution Channel
9.2.4. By Country
10. South America Over the Counter (OTC) Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Dosage Form
10.2.3. By Distribution Channel
10.2.4. By Country
11. Middle East and Africa Over the Counter (OTC) Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Dosage Form
11.2.3. By Distribution Channel
11.2.4. By Country
12. Market Dynamics
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles
14.3. Leading Players Profiled
For more information about this report visit https://www.researchandmarkets.com/r/uhrrj5
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900